Pura Vida is a healthcare-focused hedge fund with a market-neutral approach. Since inception, the firm has generated superior returns and was named Best Emerging Manager in Global Equities by Absolute Return in 2018. Pura Vida invests across the healthcare space, including medical technology and devices, biotechnology, pharmaceuticals, and healthcare services.
Location: United States, New York
Employees: 11-50
Founded date: 2012
Investors 1
| Date | Name | Website |
| - | Subversive | subversive... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 27.02.2024 | Freenome scores $254M to advance its cancer-detection blood ... | The San Francisco company readies to reveal its first clinical study results in the near term When i... | vator.tv/n... |
| 20.02.2024 | Freenome's $254M Boost for Early Cancer Detection | Freenome, a biotech company in San Francisco, just secured a massive $254M in funding to advance the... | parsers.vc... |
| 15.02.2024 | Freenome Raises $254M to Accelerate Early Cancer Detection P... | What You Should Know: – Freenome, a leader in blood-based early cancer detection, has raised $254M i... | hitconsult... |
| 29.07.2021 | Exo Raises $220M to Commercialize Handheld, Point-of-Care Ul... | What You Should Know: – Exo (pronounced “echo”), a pioneering health information and devices company... | hitconsult... |